Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 698

4.
5.

An open-label study of adjunctive modafinil in patients with sedation related to serotonergic antidepressant therapy.

Schwartz TL, Azhar N, Cole K, Hopkins G, Nihalani N, Simionescu M, Husain J, Jones N.

J Clin Psychiatry. 2004 Sep;65(9):1223-7.

PMID:
15367049
6.

Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study.

DeBattista C, Doghramji K, Menza MA, Rosenthal MH, Fieve RR; Modafinil in Depression Study Group.

J Clin Psychiatry. 2003 Sep;64(9):1057-64.

PMID:
14628981
7.

Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness.

Fava M, Thase ME, DeBattista C, Doghramji K, Arora S, Hughes RJ.

Ann Clin Psychiatry. 2007 Jul-Sep;19(3):153-9.

PMID:
17729016
8.
9.

Coadministration of modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepiness: a double-blind, placebo-controlled study.

Dunlop BW, Crits-Christoph P, Evans DL, Hirschowitz J, Solvason HB, Rickels K, Garlow SJ, Gallop RJ, Ninan PT.

J Clin Psychopharmacol. 2007 Dec;27(6):614-9.

PMID:
18004129
10.

An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder.

Iosifescu DV, Nierenberg AA, Mischoulon D, Perlis RH, Papakostas GI, Ryan JL, Alpert JE, Fava M.

J Clin Psychiatry. 2005 Aug;66(8):1038-42.

PMID:
16086620
11.

[Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].

Azorin JM, Llorca PM, Despiegel N, Verpillat P.

Encephale. 2004 Mar-Apr;30(2):158-66. French.

PMID:
15107719
12.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
13.
14.

Modafinil as adjunctive therapy in depressed outpatients.

Nasr S.

Ann Clin Psychiatry. 2004 Jul-Sep;16(3):133-8.

PMID:
15517845
15.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
17.

Effect of modafinil on fatigue, mood, and health-related quality of life in patients with narcolepsy.

Becker PM, Schwartz JR, Feldman NT, Hughes RJ.

Psychopharmacology (Berl). 2004 Jan;171(2):133-9. Epub 2003 Nov 25.

PMID:
14647965
18.

Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitors.

Papakostas GI, Nutt DJ, Hallett LA, Tucker VL, Krishen A, Fava M.

Biol Psychiatry. 2006 Dec 15;60(12):1350-5. Epub 2006 Aug 24. Review.

PMID:
16934768
20.

Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population.

Mao PX, Tang YL, Jiang F, Shu L, Gu X, Li M, Qian M, Ma C, Mitchell PB, Cai ZJ.

Depress Anxiety. 2008;25(1):46-54.

PMID:
17149753

Supplemental Content

Support Center